<?xml version="1.0" encoding="utf-8"?>
<html madcap:lastblockdepth="4" madcap:lastheight="878" madcap:lastwidth="701" xmlns:madcap="http://www.madcapsoftware.com/Schemas/MadCap.xsd" MadCap:lastBlockDepth="6" MadCap:lastHeight="522" MadCap:lastWidth="1247" xmlns:MadCap="http://www.madcapsoftware.com/Schemas/MadCap.xsd">
    <head>
        <link href="../Resources/TableStyles/dnb_tablestyle_1.css" rel="stylesheet" MadCap:stylesheetType="table" />
    </head>
    <body>
        <h1>
   OncoGenex Pharmaceuticals, Inc.
  </h1>
        <div style="display: none;">
            <table cellspacing="1" class="TableStyle-dnb_tablestyle_1" style="mc-table-style: url('../Resources/TableStyles/dnb_tablestyle_1.css');">
                <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
                </col>
                <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
                </col>
                <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
                </col>
                <thead>
                    <tr class="TableStyle-dnb_tablestyle_1-Head-Header1">
                        <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       DUNS
      </th>
                        <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       Hoovers ID
      </th>
                        <th class="TableStyle-dnb_tablestyle_1-HeadD-Column1-Header1">
       Tier
      </th>
                    </tr>
                </thead>
                <tbody>
                    <tr class="TableStyle-dnb_tablestyle_1-Body-Body1">
                        <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
       785812371
      </td>
                        <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
       44551
      </td>
                        <td class="TableStyle-dnb_tablestyle_1-BodyA-Column1-Body1" style="text-align: center;">
       3
      </td>
                    </tr>
                </tbody>
            </table>
        </div>
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Synopsis.flsnp" />
        <p>
   OncoGenex Pharmaceuticals is on the hunt for new and better cancer therapies. The company develops novel therapeutics aimed at fighting treatment-resistant tumors. Its lead candidates are custirsen (OGX-011) and apatorsen (OGX-427) -- which were gained when the firm, then-named Sonus Pharmaceuticals, merged with
   <company id="131850">
    OncoGenex Technologies
   </company>
   . Custirsen is a clinical-stage experimental drug which is being tested for the treatment of castration-resistant prostate cancer and non-small cell lung cancer. Apatorsen is being tested for the treatment of bladder cancer. After suffering some setbacks in drug trials, the company slashed its workforce by 27%, then by another 55%, in 2016.
  </p>
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" />
    </body>
</html>